TWA
ICVX

TCI Wealth Advisors’s Icosavax, Inc. Common Stock ICVX Stock Holding History

TCI Wealth Advisors’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-29
Closed -$1K – 2526
2021
Q4 		$1K Buy
+29
New +$749 ﹤0.01% 2266

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCI Wealth Advisors's ICVX Position: Q1 2022 in Review

TCI Wealth Advisors sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2022, closing a stake of 29 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in ICVX in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 65 funds tracked by Wall St. Rank hold ICVX as of Q1 2022.

  • TCI Wealth Advisors reported no remaining Icosavax, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 29 Icosavax, Inc. Common Stock shares in Q1 2022, an estimated $1K.
  • TCI Wealth Advisors first reported a position in Icosavax, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • TCI Wealth Advisors's Icosavax, Inc. Common Stock position peaked at $1K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2022.

Based on TCI Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.